Preparation and characterization of magnetic alginate-chitosan hydrogel beads loaded matrine

Drug Development and Industrial Pharmacy

Volumn 38, Issue 7, 2012, Pages 872-882

  Zhang, Ling Ling ^a   Li, Ping ^a,b   Li, Yu Min ^a,b   Wang, Ai Qin ^c  

^a LANZHOU UNIVERSITY   (China)

^b Key Laboratory of Digestive System Tumors   (China)

^c LANZHOU INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

Chitosan; Hydrogel beads; Magnetic; Matrine; PH sensitive

Indexed keywords

ALGINIC ACID; CHITOSAN; MATRINE; ALKALOID; ANTINEOPLASTIC AGENT; GLUCURONIC ACID; HEXURONIC ACID; HYDROGEL; QUINOLIZINE DERIVATIVE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; HYDROGEL; INFRARED SPECTROSCOPY; INTESTINE FLUID; MAGNETOMETRY; NEUTRON DIFFRACTION; PH; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION; CHEMISTRY; MAGNETISM; MEDICINAL CHEMISTRY; ORAL DRUG ADMINISTRATION; PROCEDURES;

ADMINISTRATION, ORAL; ALGINATES; ALKALOIDS; ANTINEOPLASTIC AGENTS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; GLUCURONIC ACID; HEXURONIC ACIDS; HYDROGELS; HYDROGEN-ION CONCENTRATION; MAGNETICS; MICROSCOPY, ELECTRON, SCANNING; QUINOLIZINES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 84861516714     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.630397     Document Type: Article

References (53)

1. Yan H, Sellick K. (2004). Quality of life of Chinese patients newly diagnosed with gastrointestinal cancer: A longitudinal study. Int J Nurs Stud, 41:309-319.
2. Yang L, Parkin DM, Li L, Chen Y. (2003). Time trends in cancer mortality in China: 1987-1999. Int J Cancer, 106:771-783.
3. Fiore FD, Cutsem EV. (2009). Acute and long-term gastrointestinal consequences of chemotherapy. Best Pract Res Clin Gastroenterol, 23:113-124.
4. Kartalou M, Essigmann JM. (2001). Mechanisms of resistance to cisplatin. Mutat Res, 478:23-43.
5. Bindseil KU, Jakupovic J, Wolf D, Lavayre J, Leboul J, van der Pyl D. (2001). Pure compound libraries; a new perspective for natural product based drug discovery. Drug Discov Today, 6:840-847.
6. Pan L, Chai H, Kinghorn AD. (2010). The continuing search for antitumor agents from higher plants. Phytochem Lett, 3:1-8.
7. Yue DF, Wang JR. (2011). Research Progress of the Natural Products against Prostate Cancer. Chinese Journal of Natural Medicines, 9:81-89.
8. Ling G, Zhang P, Zhang W, Sun J, Meng X, Qin Y et al. (2010). Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition. J Control Release, 148:241-248.
9. Song X, Zhao Y, Wu W, Bi Y, Cai Z, Chen Q et al. (2008). PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: Systematic study of particle size and drug entrapment efciency. Int J Pharm, 350: 320-329.
10. Zhigaltsev IV, Maurer N, Akhong QF, Leone R, Leng E, Wang J et al. (2005). Liposome-encapsulated vincristine, vinblastine and vinorelbine: A comparative study of drug loading and retention. J Control Release, 104:103-111.
11. Boyd BJ, Whittaker DV, Khoo SM, Davey G. (2006). Hexosomes formed from glycerate surfactants-formulation as a colloidal carrier for irinotecan. Int J Pharm, 318:154-162.
12. Hattori Y, Shi L, Ding W, Koga K, Kawano K, Hakoshima M et al. (2009). Novel irinotecan-loaded liposome using phytic acid with high therapeutic efcacy for colon tumors. J Control Release, 136:30-37.
13. Cochran MC, Eisenbrey J, Ouma RO, Soulen M, Wheatley MA. (2011). Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery. Int J Pharm, 414:161-170.
14. Wang C, Wang YJ, Wang YJ, Fan M, Luo F, Qian ZY. (2011). Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel. International Journal of Pharmaceutics, 414:251-259.
15. Sengupta S, Tyagi P, Velpandian T, Gupta YK, Gupta SK. (2000). Etoposide encapsulated in positively charged liposomes: Pharmacokinetic studies in mice and formulation stability studies. Pharmacol Res, 42:459-464.
16. Fu G, Fang Q, Feng BL, Sun SJ, Du W, Amut E, et al. (2011). Matrine-imprinted monolithic stationary phase for extraction and purifcation of matrine from Sophorae favescentis Ait. Journal of Chromatography B, 879:894-900.
17. Jiang H, Hou C, Zhang S, Xie H, Zhou W, Jin Q et al. (2007). Matrine upregulates the cell cycle protein E2F-1 and triggers apopto-sis via the mitochondrial pathway in K562 cells. Eur J Pharmacol, 559:98-108.
18. Zhang Y, Wang S, Li Y, Xiao Z, Hu Z, Zhang J. (2008). Sophocarpine and matrine inhibit the production of TNF-alpha and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice. Int Immunopharmacol, 8:1767-1772.
19. Wan XY, Luo M, Li XD, He P. (2009). Hepatoprotective and anti-hepatocarcinogenic efects of glycyrrhizin and matrine. Chemico-Biological Interactions, 181:15-19.
20. Liu JY, Hu JH, Zhu QG, Li FQ, Wang J, Sun HJ. (2007). Efect of matrine on the expression of substance P receptor and infammatory cytokines production in human skin keratinocytes and fbroblasts. Int Immunopharmacol, 7:816-823.
21. Zheng J, Zheng P, Zhou X, Yan L, Zhou R, Fu XY et al. (2009). Relaxant efects of matrine on aortic smooth muscles of guinea pigs. Biomed Environ Sci, 22:327-332.
22. Dai ZJ, Gao J, Ji ZZ, Wang XJ, Ren HT, Liu XX et al. (2009). Matrine induces apoptosis in gastric carcinoma cells via alteration of Fas/FasL and activation of caspase-3. J Ethnopharmacol, 123:91-96.
23. Luo C, Zhu Y, Jiang T, Lu X, Zhang W, Jing Q et al. (2007). Matrine induced gastric cancer MKN45 cells apoptosis via increasing pro-apoptotic molecules of Bcl-2 family. Toxicology, 229:245-252.
24. Zhang LP, Jiang JK, Tam JW, Zhang Y, Liu XS, Xu XR et al. (2001). Efects of Matrine on proliferation and diferentiation in K-562 cells. Leuk Res, 25:793-800.
25. Patwardhan B, Gautam M. (2005). Botanical immunodrugs: Scope and opportunities. Drug Discov Today, 10:495-502.
26. Wang S, Wang G, Li X, Sun J, Ma R, Sheng L. (2005). Simultaneous determination of oxymatrine and its active metabolite matrine in dog plasma by liquid chromatography-mass spectrometry and its application to pharmacokinetic studies. J Chromatogr B Analyt Technol Biomed Life Sci, 817:319-325.
27. Wu X, Yamashita F, Hashida M, Chen X, Hu Z. (2003). Determination of matrine in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies. Talanta, 59:965-971.
28. Zhang L, Liu W, Zhang R, Wang Z, Shen Z, Chen X et al. (2008). Pharmacokinetic study of matrine, oxymatrine and oxysophocarpine in rat plasma after oral administration of Sophora favescens Ait. extract by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal, 47:892-898.
29. Yang Z, Gao S, Yin T, Kulkarni KH, Teng Y, You M et al. (2010). Biopharmaceutical and pharmacokinetic characterization of matrine as determined by a sensitive and robust UPLC-MS/MS method. J Pharm Biomed Anal, 51:1120-1127.
30. Dash M, Chiellini F, Ottenbrite RM, Chiellini E. (2011). Chitosan-A versatile semi-synthetic polymer in biomedical applications. Progress in Polymer Science, 36:981-1014.
31. Rinaudo M. (2006). Chitin and chitosan: Properties and applications. Progress in Polymer Science, 31:603-632.
32. Baldrick P. (2010). The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharmacol, 56:290-299.
33. Hoemann CD, Sun J, Légaré A, McKee MD, Buschmann MD. (2005). Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle. Osteoarthr Cartil, 13: 318-329.
34. Ji QX, Zhong de Y, Lü R, Zhang WQ, Deng J, Chen XG. (2009). In vitro evaluation of the biomedical properties of chitosan and quaternized chitosan for dental applications. Carbohydr Res, 344:1297-1302.
35. Simi SP, Saraswathi R, Sankar C, Krishnan PN, Dilip C, Ameena K. (2010). Formulation and evaluation of Albendazole microcapsules for colon delivery using chitosan. Asian Pacifc Journal of Tropical Medicine, 3: 374-378.
36. Wu HD, Yang JC, Tsai T, Ji DY, Chang WJ, Chen CC, et al.(2011). Development of a chitosan-polyglutamate based injectable poly-electrolyte complex scafold. Carbohydrate Polymers, 85:318-324.
37. Zhang GJ, Gao X, Ji SL, Liu ZZ. (2009). One-step dynamic assembly of polyelectrolyte complex membranes. Materials Science and Engineering C, 29:1877-1884.
38. Draget KI, Skjåk-Braek G, Smidsrød O. (1997). Alginate based new materials. Int J Biol Macromol, 21:47-55.
39. Draget, et al. 2011
40. Alexiou C, Jurgons R, Schmid R, Hilpert A, Bergemannc C, Parak F, et al. (2005). In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles. Journal of Magnetism and Magnetic Materials, 293:389-393.
41. Chomoucka J, Drbohlavova J, Huska D, Adam V, Kizek R, Hubalek J. (2010). Magnetic nanoparticles and targeted drug delivering. Pharmacol Res, 62:144-149.
42. Cole AJ, Yang VC, David AE. (2011). Cancer theranostics: The rise of targeted magnetic nanoparticles. Trends Biotechnol, 29: 323-332.
43. Zhang RY, Wu CH, Wang XM, Sun Q, Chen BA, Li XM, et al. (2009). Enhancement efect of nano Fe3O4 to the drug accumulation of doxorubicin in cancer cells. Materials Science and Engineering C 29:1697-1701.
44. Yang WC, Xie R, Pang XQ, Ju XJ, Chu LY. (2008). Preparation and characterization of dual stimuli-responsive microcapsules with a superparamagnetic porous membrane and thermo-responsive gates. Journal of Membrane Science, 321:324-330.
45. Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB. (2007). Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: Optimization and physico-chemical characterization. Eur J Pharm Biopharm, 65:215-232.
46. Qi L, Xu Z, Jiang X, Hu C, Zou X. (2004). Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr Res, 339:2693-2700.
47. Fan LH, Du YM, Zhang BZ, Yang JH, Zhou JP, Kennedy JF. (2006). Preparation and properties of alginate/carboxymethyl chitosan blend fbers. Carbohydrate Polymers, 65:447-452.
48. Yang G, Zhang LN, Peng T, Zhong W. (2000). Efects of Ca2+ Bridge cross-linking on structure and pervaporation of cellulose/alginate blend membranes. Journal of Membrane Science, 175:53-60.
49. Karaoglu EK, Baykal A, Deligöz H, Senel M, Sözeri H, Toprak MS. (2011). Synthesis and characteristics of Poly (3-pyrrol-1-ylpropanoic acid) (PPyAA)-Fe3O4 Nanocomposite. Journal of Alloys and Compounds.
50. Liu HJ, Li P, Wei Q. (2010). Magnetic N-succinyl chitosan/alginate beads for carbamazepine delivery. Drug Dev Ind Pharm, 36:1286-1294.
51. Bajpai SK, Sharma S. Investigation of swelling/degradation behavior of alginate beads crosslinked with Ca2+ and Ba2+ ions. Reactive & Functional Polymers, 2004, 59:129-140.
52. Wang FQ, Li P, Zhang JP, et al.(2010). pH sensitive magnetic alginate-chitosan beads for albendazole delivery. Pharmaceutical Development and Technology, 16: 228-236.
53. Wang FQ, Li P, Zhang JP, Wang AQ, Wei Q. (2010). A novel pH-sensitive magnetic alginate-chitosan beads for albendazole delivery. Drug Dev Ind Pharm, 36:867-877.